NCT00005625View on ClinicalTrials.gov

Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Sarcoma
Interventions
DRUG

trabectedin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005625 - Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma | Biotech Hunter | Biotech Hunter